Dr. Amy Becker, MD

NPI: 1124037643
Total Payments
$85,777
2024 Payments
$12,937
Companies
13
Transactions
115

Payment Breakdown by Category

Other$56,499 (65.9%)
Consulting$14,400 (16.8%)
Travel$12,099 (14.1%)
Food & Beverage$2,719 (3.2%)
Education$60.00 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $56,349 23 65.7%
Consulting Fee $14,400 2 16.8%
Travel and Lodging $12,099 32 14.1%
Food and Beverage $2,719 55 3.2%
Honoraria $150.00 1 0.2%
Education $60.00 2 0.1%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $84,730 80 $0 (2024)
Alexion Pharmaceuticals, Inc. $477.96 12 $0 (2024)
GlaxoSmithKline, LLC. $146.38 3 $0 (2023)
Aurinia Pharma U.S., Inc. $119.13 6 $0 (2024)
Ultragenyx Pharmaceutical Inc. $80.42 3 $0 (2021)
Amicus Therapeutics, Inc. $68.92 4 $0 (2023)
Novo Nordisk Inc $35.78 1 $0 (2023)
Alnylam Pharmaceuticals Inc. $28.61 1 $0 (2023)
Kyowa Kirin, Inc. $25.85 1 $0 (2024)
SPACELABS HEALTHCARE INC $21.66 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $12,937 11 GENZYME CORPORATION ($12,821)
2023 $29,125 37 GENZYME CORPORATION ($28,910)
2022 $14,048 20 GENZYME CORPORATION ($13,951)
2021 $13,844 17 GENZYME CORPORATION ($13,512)
2020 $1,187 3 GENZYME CORPORATION ($1,176)
2019 $6,201 15 GENZYME CORPORATION ($5,945)
2018 $8,415 11 GENZYME CORPORATION ($8,415)
2017 $20.68 1 Alexion Pharmaceuticals, Inc. ($20.68)

All Payment Transactions

115 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
10/24/2024 GENZYME CORPORATION FABRAZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,230.00 General
Category: Genetic Disease
09/11/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $17.63 General
Category: Rare Disease
08/22/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $13.29 General
Category: LUPUS NEPHRITIS
08/21/2024 Kyowa Kirin, Inc. Crysvita (Drug) Food and Beverage In-kind items and services $25.85 General
Category: fibroblast growth factor 23 (FGF23) blocking antibody.
07/13/2024 GENZYME CORPORATION FABRAZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,007.00 General
Category: Genetic Disease
07/13/2024 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging Cash or cash equivalent $360.46 General
Category: Genetic Disease
07/13/2024 GENZYME CORPORATION FABRAZYME (Biological) Food and Beverage In-kind items and services $38.48 General
Category: Genetic Disease
06/01/2024 GENZYME CORPORATION Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,185.00 General
04/30/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $28.77 General
Category: Rare Disease
04/29/2024 Tolmar, Inc. FENSOLVI (Drug) Food and Beverage Cash or cash equivalent $13.33 General
Category: HORMONE REPLACEMENT
01/29/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $16.71 General
Category: Rare Disease
12/02/2023 GENZYME CORPORATION CERDELGA (Drug) Consulting Fee Cash or cash equivalent $6,000.00 General
Category: Genetic Disease
12/02/2023 GENZYME CORPORATION CERDELGA (Drug) Travel and Lodging In-kind items and services $540.50 General
Category: Genetic Disease
12/02/2023 GENZYME CORPORATION CERDELGA (Drug) Travel and Lodging In-kind items and services $229.25 General
Category: Genetic Disease
12/02/2023 GENZYME CORPORATION CERDELGA (Drug) Travel and Lodging In-kind items and services $147.38 General
Category: Genetic Disease
12/02/2023 GENZYME CORPORATION CERDELGA (Drug) Food and Beverage In-kind items and services $133.89 General
Category: Genetic Disease
12/02/2023 GENZYME CORPORATION CERDELGA (Drug) Food and Beverage In-kind items and services $69.63 General
Category: Genetic Disease
12/02/2023 GENZYME CORPORATION CERDELGA (Drug) Food and Beverage In-kind items and services $51.59 General
Category: Genetic Disease
12/02/2023 GENZYME CORPORATION CERDELGA (Drug) Food and Beverage In-kind items and services $49.15 General
Category: Genetic Disease
12/01/2023 GlaxoSmithKline, LLC. JESDUVROQ (Drug), BENLYSTA Food and Beverage In-kind items and services $18.13 General
Category: NEPHROLOGY
11/27/2023 GENZYME CORPORATION FABRAZYME (Biological) Food and Beverage In-kind items and services $107.14 General
Category: Genetic Disease
10/13/2023 GENZYME CORPORATION FABRAZYME (Biological) Consulting Fee Cash or cash equivalent $8,400.00 General
Category: Genetic Disease
10/13/2023 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging In-kind items and services $751.50 General
Category: Genetic Disease
10/13/2023 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging In-kind items and services $404.67 General
Category: Genetic Disease
10/13/2023 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging In-kind items and services $162.64 General
Category: Genetic Disease

About Dr. Amy Becker, MD

Dr. Amy Becker, MD is a Pediatric Nephrology healthcare provider based in Corpus Christi, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124037643.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Becker, MD has received a total of $85,777 in payments from pharmaceutical and medical device companies, with $12,937 received in 2024. These payments were reported across 115 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($56,349).

Practice Information

  • Specialty Pediatric Nephrology
  • Location Corpus Christi, TX
  • Active Since 08/05/2006
  • Last Updated 10/28/2020
  • Taxonomy Code 2080P0210X
  • Entity Type Individual
  • NPI Number 1124037643

Products in Payments

  • FABRAZYME (Biological) $58,431
  • FABRAZYME (Drug) $14,360
  • CERDELGA (Drug) $7,221
  • ULTOMIRIS (Biological) $168.88
  • Soliris (Drug) $150.00
  • SOLIRIS (Drug) $145.68
  • BENLYSTA (Biological) $128.25
  • LUPKYNIS (Drug) $119.13
  • Crysvita (Drug) $46.27
  • GALAFOLD (Drug) $30.89
  • OXLUMO (Drug) $28.61
  • JESDUVROQ (Drug) $18.13
  • Qbrelis (Drug) $18.05
  • Ultomiris (Drug) $13.40
  • FENSOLVI (Drug) $13.33
  • Epaned (Drug) $11.04

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Nephrology Doctors in Corpus Christi